115
Views
15
CrossRef citations to date
0
Altmetric
Original

Engineered carbon nanoparticles alter macrophage immune function and initiate airway hyper-responsiveness in the BALB/c mouse model

, , , , &
Pages 104-117 | Published online: 10 Jul 2009
 

Abstract

With the mass production of fullerenes currently underway, and the mass production of carbon nanotubes soon to follow, only a few studies have examined the biological consequences of manmade nanoparticle exposure in the mammalian system. This study examines carbon nanoparticle (CNP) exposure in both in vitro (murine BALB/c alveolar macrophages) and in vivo (murine BALB/c intranasal instillations) systems. Three types of CNP were examined (single-walled nanotubes, multi-walled nanotubes, and C60 fullerenes). In vitro macrophage experiments included measurements of morphology changes, apoptosis, viability, and antigen-presenting cell function in response to CNP exposure. In vivo mouse experiments determined the inflammatory potential of CNP exposure in the lung using a BUXCO™ apparatus along with cell differentials and cell morphology. This study presents evidence that CNP, accumulated in the plasma membranes of cells (disrupting lipid rafts), increased alveolar macrophage function with regard to antigen-presentation, significantly exacerbated airway hyper-responsiveness, and caused an influx of macrophages into the lung by posited mechanisms that involve the unique molecular and physical properties of CNP.

Acknowledgements

EM images and technical assistance were provided by Roy Pescador in the Division of Biological Sciences, University of Montana. Funding for this research was provided by ES-11120 from the NIEHS and COBRE grant P20-RR-017670 from NCRR.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.